RACE for Children Act Opens New Avenues for Pediatric Oncology Drug Development

With the long-anticipated ignition of the Research to Accelerate Cures and Equity (RACE) for Children Act on Tuesday (August 18) this week, stakeholders in the development of oncology drugs—ranging from patients and their families to clinical research sponsors and practitioners—have new hopes for advancements in more effective therapies for pediatric cancers.

According to Lynne Georgopoulos, RN, MSHS, RAC, and S. Y. Amy Cheung, PhD…

Author(s): Gary Cramer

トップに戻る
Powered by Translations.com GlobalLink OneLink Software